Impact of gastroesophageal reflux on survival in the community

American Journal of Gastroenterology

Volumn 103, Issue 1, 2008, Pages 12-19

  Talley, Nicholas J ^a,c   Richard Locke III, G ^a   McNally, M ^a   Schleck, Cathy D ^b   Zinsmeister, Alan R ^b   Joseph Melton III, L ^b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BARRETT ESOPHAGUS; BODY MASS; CANCER MORTALITY; CAUSE OF DEATH; COMORBIDITY; DEMOGRAPHY; EDUCATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GENDER; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; SURVIVAL; SYMPTOMATOLOGY; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CONFIDENCE INTERVALS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FLORIDA; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 37849046680     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01546.x     Document Type: Article

References (38)

1. Locke GR 3rd., Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota. Gastroenterology 1997 112 : 1448 56.
2. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet 2006 367 : 2086 100.
3. Nandurkar S, Locke GR 3rd., Murray JA, et al. Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol 2005 100 : 1459 65.
4. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999 340 : 825 31.
5. Chow WH, Finkle WD, McLaughlin JK, et al. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995 274 : 474 7.
6. Farrow DC, Vaughan TL, Sweeney C, et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 2000 11 : 231 8.
7. Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer. JAMA 2002 287 : 1972 81.
8. Bytzer P, Christensen PB, Damkier P, et al. Adenocarcinoma of the esophagus and Barrett's esophagus: A population-based study. Am J Gastroenterol 1999 94 : 86 91.
9. DeVault KR, Castell DO. Updated guildelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005 100 : 190 200.
10. Fox M, Forgacs I. Gastro-oesophageal reflux disease. BMJ 2006 332 : 88 93.
11. Hancox RJ, Poulton R, Taylor DR, et al. Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort. Respir Res 2006 7 : 142.
12. Melton LJ 3rd. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996 71 : 266 74.
13. Melton LJ 3rd. The threat to medical-records research. N Engl J Med 1997 337 : 1466 70.
14. Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: A population-based study. Gastroenterology 1992 102 : 1259 68.
15. Talley N, Weaver A, Zinsmeister A, et al. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992 136 : 165 77.
16. Talley NJ, Weaver AL, Zinsmeister AR, et al. Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups. Am J Gastroenterol 1994 89 : 524 8.
17. Talley NJ, Fett SL, Zinsmeister AR, et al. Gastrointestinal tract symptoms and self-reported abuse: A population-based study. Gastroenterology 1994 107 : 1040 9.
18. Locke GR 3rd., Zinsmeister AR, Talley NJ, et al. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 2000 75 : 907 12.
19. Locke GR 3rd., Weaver AL, Melton LJ 3rd., et al. Psychosocial factors are linked to functional gastrointestinal disorders: A population based nested case-control study. Am J Gastroenterol 2004 99 : 350 7.
20. Vege SS, Locke GR 3rd., Weaver AL, et al. Functional gastrointestinal disorders among people with sleep disturbances: A population-based study. Mayo Clin Proc 2004 79 : 1501 6.
21. Talley N, Phillips S, Wiltgen C, et al. Assessment of functional gastrointestinal disease: The bowel disease questionnaire. Mayo Clin Proc 1990 65 : 1456 79.
22. Locke GR, Talley NJ, Weaver AL, et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994 69 : 539 47.
23. O'Keefe EA, Talley NJ, Tangalos EG, et al. A bowel symptom questionnaire for the elderly. J Gerontol 1992 47 : M116 21.
24. Locke GR, Zinsmeister AR, Talley NJ. Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc 2003 58 : 661 70.
25. ® commercial location and research online service. 2005. Available at : http://www.accurint. com.
26. Rocca WA, Grossardt BR, de Andrade M, et al. Survival patterns after oophorectomy in premenopausal women: A population-based cohort study. Lancet Oncol 2006 7 : 821 8.
27. Kyle RA, Therneau TM, Rajkumar SV, et al. Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades. Cancer 2004 101 : 2667 74.
28. Bambha K, Kim WR, Talwalkar J, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003 125 : 1364 9.
29. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987 40 : 373 83.
30. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992 45 : 613 9.
31. Rantanen TK, Sihvo EIT, Räsänen J, et al. Gastroesophageal reflux disease as a cause of death is increasing: Analysis of fatal cases after medical and surgical treatment. Am J Gastroenterol 2007 102 : 246 53.
32. Crane SJ, Locke GR 3rd., Harmsen WS, et al. The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site. Aliment Pharmacol Ther 2007 25 : 447 53.
33. Ruigomez A, Garcia Rodriguez LA, Wallander MA, et al. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 2004 20 : 751 60.
34. Bateman DN, Colin-Jones D, Hartz S, et al. Mortality study of 18000 patients treated with omeprazole. Gut 2003 52 : 942 6.
35. Solaymani-Dodaran M, Logan RF, West J, et al. Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses - a population-based cohort study. Am J Gastroenterol 2005 100 : 2616 21.
36. Mukamal KJ, Conigrave KM, Mittleman MA, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003 348 : 109 18.
37. Gaziano JM, Gaziano TA, Glynn RJ, et al. Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol 2000 35 : 96 105.
38. Lagergren J, Bergstrom R, Adami HO, et al. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med 2000 133 : 165 75.